These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 2324159)
21. Comparison of anti-androgenic activity of flutamide, vinclozolin, procymidone, linuron, and p, p'-DDE in rodent 10-day Hershberger assay. Kang IH; Kim HS; Shin JH; Kim TS; Moon HJ; Kim IY; Choi KS; Kil KS; Park YI; Dong MS; Han SY Toxicology; 2004 Jul; 199(2-3):145-59. PubMed ID: 15147789 [TBL] [Abstract][Full Text] [Related]
22. The changes in the binding capacity of testosterone-oestradiol binding globulin (TeBG) following castration and DES-D administration in patients with prostatic carcinoma. Usui T; Sagami K; Kitano T; Nihira H; Miyachi Y Urol Res; 1982; 10(3):119-22. PubMed ID: 6890254 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of the cytotoxic activity of diethylstilbestrol and its mono- and diphosphate towards prostatic carcinoma cells. Schulz P; Bauer HW; Brade WP; Keller A; Fittler F Cancer Res; 1988 May; 48(10):2867-70. PubMed ID: 2834049 [TBL] [Abstract][Full Text] [Related]
24. Suppression of diethylstilbestrol and N-nitrosobutylurea-induced mammary and pituitary tumorigenesis in rats by prolonged treatment with 2-bromoergocryptine. Sumi C; Yokoro K; Matsushima R Cancer Res; 1983 Oct; 43(10):4781-5. PubMed ID: 6883334 [TBL] [Abstract][Full Text] [Related]
25. Influence of diethylstilbestrol, Leuprolelin (a luteinizing hormone-releasing hormone analog), Finasteride (a 5 alpha-reductase inhibitor), and castration on the lobar subdivisions of the rat prostate. Yamashita A; Hayashi N; Sugimura Y; Cunha GR; Kawamura J Prostate; 1996 Jul; 29(1):1-14. PubMed ID: 8685049 [TBL] [Abstract][Full Text] [Related]
26. Basal and estrogen-stimulated hormone receptor profiles in four R3327 rat prostatic carcinoma sublines in relation to histopathology and androgen sensitivity. Mobbs BG; Johnson IE Cancer Res; 1988 Jun; 48(11):3077-83. PubMed ID: 3259159 [TBL] [Abstract][Full Text] [Related]
27. Induction of reproductive tract developmental abnormalities in the male rat by lowering androgen production or action in combination with a low dose of diethylstilbestrol: evidence for importance of the androgen-estrogen balance. Rivas A; Fisher JS; McKinnell C; Atanassova N; Sharpe RM Endocrinology; 2002 Dec; 143(12):4797-808. PubMed ID: 12446607 [TBL] [Abstract][Full Text] [Related]
28. A comparison of the effects of castration and 6-methylene progesterone, a 5 alpha-reductase inhibitor, on the rat ventral prostate. Marts SA; Padilla GM; Petrow V Biochem Cell Biol; 1987 Jul; 65(7):626-34. PubMed ID: 3435660 [TBL] [Abstract][Full Text] [Related]
29. The antiandrogenic effects of delta 1-testolactone (Teslac) in vivo in rats and in vitro in human cultured fibroblasts, rat mammary carcinoma cells, and rat prostate cytosol. Vigersky RA; Mozingo D; Eil C; Purohit V; Bruton J Endocrinology; 1982 Jan; 110(1):214-9. PubMed ID: 7053985 [TBL] [Abstract][Full Text] [Related]
30. [Drug therapy of metastasizing prostate carcinoma with special reference to the bioavailability of fosfestrol after oral administration]. Oelschläger H; Rothley D; Dunzendorfer U Arzneimittelforschung; 1988 Oct; 38(10):1502-12. PubMed ID: 3058134 [TBL] [Abstract][Full Text] [Related]
31. Effects of 17 beta-estradiol and diethylstilbestrol on concurrent development of hepatic, mammary, and pituitary tumors in WF rats: evidence for differential effect on liver. Sumi C; Yokoro K; Matsushima R J Natl Cancer Inst; 1984 Nov; 73(5):1229-34. PubMed ID: 6593493 [TBL] [Abstract][Full Text] [Related]
32. A comparison of in vitro and in vivo EDSTAC test battery results for detecting antiandrogenic activity. Charles GD; Kan HL; Schisler MR; Bhaskar Gollapudi B; Sue Marty M Toxicol Appl Pharmacol; 2005 Jan; 202(1):108-20. PubMed ID: 15589981 [TBL] [Abstract][Full Text] [Related]
33. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer. Long BJ; Grigoryev DN; Nnane IP; Liu Y; Ling YZ; Brodie AM Cancer Res; 2000 Dec; 60(23):6630-40. PubMed ID: 11118046 [TBL] [Abstract][Full Text] [Related]
34. Androgens regulate brain aromatase activity in adult male rats through a receptor mechanism. Roselli CE; Resko JA Endocrinology; 1984 Jun; 114(6):2183-9. PubMed ID: 6723579 [TBL] [Abstract][Full Text] [Related]
35. Comparative effects and mechanisms of castration, estrogen anti-androgen, and anti-estrogen-induced regression of accessory sex organ epithelium and muscle. Neubauer B; Blume C; Cricco R; Greiner J; Mawhinney M Invest Urol; 1981 Jan; 18(4):229-34. PubMed ID: 7451082 [TBL] [Abstract][Full Text] [Related]
36. Liposome-entrapped diethylstilbestrol effect on prostate gland and plasma testosterone levels in rats. Jackson AJ; Franklin RB Endocrinology; 1984 Aug; 115(2):538-43. PubMed ID: 6745169 [TBL] [Abstract][Full Text] [Related]
37. Synergistic effect of testosterone and of a luteinizing hormone-releasing hormone agonist on androgen receptor content in the ventral prostate of castrated rats. Fiorelli G; Zoppi S; Kohen F; Motta M Steroids; 1989; 53(1-2):195-217. PubMed ID: 2505407 [TBL] [Abstract][Full Text] [Related]
38. In vivo selection of androgen-insensitive cells in R3327-G rat prostate tumors: diethylstilbestrol diphosphate treatment versus orchiectomy. Pollack A; Block NL; Stover BJ; Irvin GL; Fuentes MP; Claflin AJ; Malinin TI J Natl Cancer Inst; 1983 May; 70(5):907-14. PubMed ID: 6573535 [TBL] [Abstract][Full Text] [Related]
39. Radioimmunoassay of diethylstilbestrol in plasma of patients with prostatic carcinoma. Usui T; Nakamura K; Osumi T; Ishibe T; Kitano T; Kambegawa A; Miyachi Y Arch Androl; 1984; 12(2-3):243-9. PubMed ID: 6508431 [TBL] [Abstract][Full Text] [Related]
40. Effect of coumarin on the normal rat prostate and on the R-3327H prostatic adenocarcinoma. Omarbasha B; Fair WR; Heston WD Cancer Res; 1989 Jun; 49(11):3045-9. PubMed ID: 2720665 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]